Literature DB >> 25981817

SABR in early operable lung cancer: time for evidence.

Tom Treasure1, Robert C Rintoul2, Fergus Macbeth3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25981817     DOI： 10.1016/S1470-2045(15)70225-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.

Authors:  Jan P van Meerbeeck; Halil Sirimsi
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

3.  Stage I lung cancer-to operate or to radiate? that is the question.

Authors:  Boris Sepesi; David C Rice; John V Heymach; Ara A Vaporciyan; Stephen G Swisher
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 4.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

5.  [Stereotactic Ablative Radiotherapy for Operable Stage I Non-small Cell Lung Cancer in Clinical Practice: How Long Way to Go?].

Authors:  Xiaolong Fu; Xuwei Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-07

6.  Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.

Authors:  Sahar Mokhles; Fergus Macbeth; Tom Treasure; Riad N Younes; Robert C Rintoul; Francesca Fiorentino; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  Eur J Cardiothorac Surg       Date:  2017-06-01       Impact factor: 4.191

7.  Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.

Authors:  S Mokhles; J J M E Nuyttens; M de Mol; J G J V Aerts; A P W M Maat; Ö Birim; A J J C Bogers; J J M Takkenberg
Journal:  BMC Cancer       Date:  2018-01-15       Impact factor: 4.430

8.  Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.

Authors:  Austin Lammers; Timur Mitin; Drew Moghanaki; Charles R Thomas; Robert Timmerman; Sara E Golden; Sujata Thakurta; Rafal Dziadziuszko; Christopher G Slatore
Journal:  Adv Radiat Oncol       Date:  2018-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.